Table: begin end state 1 31 non-cytoplasmic 32 53 transmembrane 54 64 cytoplasmic 65 87 transmembrane 88 97 non-cytoplasmic 98 118 transmembrane 119 123 cytoplasmic 124 146 transmembrane 147 167 non-cytoplasmic 168 188 transmembrane 189 199 cytoplasmic 200 218 transmembrane 219 240 non-cytoplasmic 241 263 transmembrane 264 274 cytoplasmic 275 300 transmembrane 301 320 non-cytoplasmic 321 343 transmembrane 344 372 cytoplasmic 373 392 transmembrane 393 397 non-cytoplasmic 398 417 transmembrane 418 428 cytoplasmic 429 449 transmembrane 450 454 non-cytoplasmic 455 473 transmembrane 474 486 cytoplasmic
Input: >BPHYT_RS33230 MADTSYMARKSVADIVGSADADEGHSLSKSLGAISITAMGIGAIIGAGIFVLTGTAAAQF AGPSIVLSFVLGGIACAFVGLCYSELAAMLPVCGSSYTYTYATLGEIFAWIIGWDLILEY AMGAATVAVGWSGYIVSLLHNVGISIPPVLATAPGTVIKLADGTTATGIVNLPAIVIIAI LTTMLVLGTKESARLNNIMVAVKLVVVVAFIALGVFFIKPANWHPFIPANTGEFGNFGMS GILRGSAVVFFAFIGFDAVSTAAQEAKKPQRDMPIGILGSLIICTILYILVAGVLTGLVP YAELNVPDPIAKGVDAIGLNWFSILIKIGALTGLTTVILVLLYGQSRIFFTMSTDGLLPP LFARVHPRLQTPYLSQILIGSVVAIVAALTPISVLGEMVSIGTLFAFILVCGAVIYLRRS DSDASRPFRVPGVPVVPVLGILFCLLLMAGLPLVTWVRLVVWLVIGMTIYMSYGRNHSRL RYPERH
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server